Post Job

ResMed's revenue is $4.7 billion.

What is ResMed's revenue?

ResMed's annual revenue is $4.7B. Zippia's data science team found the following key financial metrics about ResMed after extensive research and analysis.
  • ResMed's revenue growth from 2003 to 2024 is 1,612.65%.
  • ResMed has 8,000 employees, and the revenue per employee ratio is $585,662.
  • ResMed's peak quarterly revenue was $1.3B in 2025(q2).
  • ResMed peak revenue was $4.7B in 2024.
  • ResMed annual revenue for 2023 was 4.2B, 18.02% growth from 2022.
  • ResMed annual revenue for 2024 was 4.7B, 10.95% growth from 2023.

On This Page

Most Recent Quarter Revenue
$1.3B (Q2'2025)
Company Most Recent Quarter Revenue
Peak Revenue
$4.7B (2024)
Company Peak Revenue
Revenue / Employee
$585,662
Company Revenue / Employee

We apply to jobs. You watch Netflix. Only $10.

Floating question marks illustration
Most Recent Quarter Revenue
$1.3B (Q2'2025)
Company Most Recent Quarter Revenue
Peak Revenue
$4.7B (2024)
Company Peak Revenue
Revenue / Employee
$585,662
Company Revenue / Employee

ResMed historical revenue

ResMed's peak revenue was $4.7B in 2024. The peak quarterly revenue was $1.3B in 2025(q2).

ResMed's revenue increased from $273.6m in 2003 to $4.7B currently. That's a 1,612.65% change in annual revenue.

ResMed annual revenue

$5B
$4B
$3B
$2B
$937M
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024

ResMed annual revenue over time

Fiscal Year / YearResMed Revenue
2009$920.7M
2010$1.1B
2011$1.2B
2012$1.4B
2013$1.5B
2014$1.6B
2015$1.7B
2016$1.8B
2017$2.1B
2018$2.3B
2019$2.6B
2020$3.0B
2021$3.2B
2022$3.6B
2023$4.2B
2024$4.7B

Rate ResMed's financial transparency

Zippia waving zebra

ResMed annual growth

ResMed saw the greatest revenue growth in 2006, when revenue increased by 42.65%.

ResMed had the lowest revenue growth in 2014, when revenue changed by 2.68%.

ResMed annual growth rate over time

YearResMed Growth
2009
10%
2010
19%
2011
14%
2012
10%
2013
11%
2014
3%
2015
8%
2016
10%
2017
12%
2018
13%
2019
11%
2020
13%
2021
8%
2022
12%
2023
18%
2024
11%

ResMed quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$1B
$1B
$769M
$513M
$256M
$0
2021
2022
2023
2024
2025

ResMed quarterly growth rate over time

YearQ1Q2Q3Q4
2009$217.9M$223.0M$227.9M$252.0M
2010$247.0M$275.1M$278.7M$291.6M
2011$282.0M$306.0M$313.3M$341.9M
2012$314.8M$332.7M$349.1M$371.9M
2013$339.7M$376.5M$383.6M$414.6M
2014$357.7M$384.3M$397.8M$415.2M
2015$380.4M$423.0M$422.5M$453.1M
2016$411.6M$454.5M$453.9M$518.6M
2017$465.5M$530.4M$514.2M$556.7M
2018$523.7M$601.3M$591.6M$623.6M
2019$588.3M$651.1M$662.2M$705.0M
2020$681.1M$736.2M$769.5M$770.3M
2021$751.9M$800.0M$768.8M$876.1M
2022$904.0M$894.9M$864.5M$914.7M
2023$950.3M$1.0B$1.1B$1.1B
2024$1.1B$1.2B$1.2B$1.2B
2025$1.2B$1.3B--

ResMed Jobs Nearby

Do you work at ResMed?

Is ResMed transparent about its revenue structure?

ResMed Financial Information

CEOMichael “Mick” Farrell
IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number8,000
Date Founded1989
HeadquartersSan Diego, California
Number of Locations4
Revenue$4.7B
Net Income$897,556,000
Gross Proft$2.7B (2024)
EBITDA$1.4B (2024)
PE Ratio13.07
Tax Rate0.2%
Market Capitalization$13.3B
Total Assets$6,751,708,000
TickerRMD

ResMed Jobs You Might Like

ResMed Financing

ResMed received early financing of $500.0M on 2019-07-15.

SeriesRound SizeDate
Post Ipo Debt$500M07/2019

ResMed competitors

ResMed's top competitor, McKesson, earned an annual revenue of $309.0B.

ResMed's smallest competitor is Achieve Services with revenue of $480.0K last year.

ResMed Revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of ResMed, including salaries, political affiliations, employee data, and more, in order to inform job seekers about ResMed. The employee data is based on information from people who have self-reported their past or current employments at ResMed. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by ResMed. The data presented on this page does not represent the view of ResMed and its employees or that of Zippia.

ResMed may also be known as or be related to ResMed, ResMed Inc, ResMed Inc., ResMed, Inc. and Resmed Inc.